Although the general benefits of lowering high blood pressure are widely accepted, there has been intense debate over specific goals for treatment and the threshold at which therapy should be initiated. A large new meta-analsysis published in JAMA helps shed lights on this important controversy.
UK and Australian researchers analyzed the effect of lowering blood pressure in people with type 2 diabetes using data from more than 100,00 people who participated in 40 trials.
…
Click here to read the full post on Forbes.
Speak Your Mind